TransCode Therapeutics, Inc. - Common Stock (RNAZ)
Seasonality Analysis
TransCode Therapeutics, Inc. - Common Stock Annual Seasonality Statistics
TransCode Therapeutics, Inc. - Common Stock Monthly Seasonality Performance
| Month | Avg Return | Win Rate | Strength |
|---|---|---|---|
| January | 10.62% | Moderate | |
| February | -24.03% | Weak | |
| March | -17.96% | Very Weak | |
| April | -9.58% | Very Weak | |
| May | 13.93% | Weak | |
| June WORST | -25.12% | Very Weak | |
| July | -8.30% | Weak | |
| August | -12.07% | Very Weak | |
| September BEST | 15.33% | Moderate | |
| October | -11.17% | Very Weak | |
| November | -24.37% | Very Weak | |
| December | -10.55% | Very Weak |
TransCode Therapeutics, Inc. - Common Stock 2026 vs Historical Pattern
TransCode Therapeutics, Inc. - Common Stock Interactive Seasonality Chart
TransCode Therapeutics, Inc. - Common Stock Pattern Scanner
TransCode Therapeutics, Inc. - Common Stock Seasonal Historical Performance
About TransCode Therapeutics, Inc. - Common Stock (RNAZ) Seasonality
TransCode Therapeutics, Inc. - Common Stock (RNAZ) has been analyzed using 5 years of historical data to identify seasonal patterns. Classified under Stocks, TransCode Therapeutics, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.
The strongest month for TransCode Therapeutics, Inc. - Common Stock is historically September, with an average return of 15.33% and a win rate of 60%. Conversely, June tends to be the weakest month, averaging -25.12% return.
Looking at the full calendar year, TransCode Therapeutics, Inc. - Common Stock has an average annual return of -103.28% with an overall monthly win rate of 29.2%. Out of 12 months, 3 typically show positive average returns.
The seasonal pattern for TransCode Therapeutics, Inc. - Common Stock has a consistency score of 65.2 (Good), based on 6 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.
TransCode Therapeutics, Inc. - Common Stock Seasonality FAQ
What is the best month to buy TransCode Therapeutics, Inc. - Common Stock (RNAZ)?
Historically, September has been the best month for TransCode Therapeutics, Inc. - Common Stock, with an average return of 15.33% and a win rate of 60%. However, past performance does not guarantee future results.
What is the worst month for TransCode Therapeutics, Inc. - Common Stock (RNAZ)?
Based on historical data, June has been the weakest month for TransCode Therapeutics, Inc. - Common Stock, with an average return of -25.12%. This is a historical observation and does not guarantee future results.
How reliable is RNAZ seasonality data?
The seasonality analysis for TransCode Therapeutics, Inc. - Common Stock is based on 5 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.
How can I use TransCode Therapeutics, Inc. - Common Stock seasonality in my trading?
Use TransCode Therapeutics, Inc. - Common Stock (RNAZ) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.